Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease

NCT07187167 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Rosai-Dorfman Disease

Interventions

DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences